August 22, 2014 6:30 AM ET

Pharmaceuticals

Company Overview of Mega Lifesciences Public Company Limited

Company Overview

Mega Lifesciences Public Company Limited develops, manufactures, markets, and sells nutraceutical products, generic prescription pharmaceutical products, and OTC products under the brand name of Mega We Care. It also distributes pharmaceutical products, OTC products, and fast moving consumer goods in Myanmar, Vietnam, and Cambodia. The company provides Mega We Care branded generic prescription pharmaceutical products in the therapeutic areas of cardiology, dermatology, diabetics, gastroenterology, neurology, ortho, respiratory, and urology. In addition, it offers complementary medicines comprising children, diabetics, heart health, herbals, joint health, liver tonic, men’s and women’s health...

Ample Tower Bangna

10th Floor

120, Moo 11

Bangna

Bangkok,  10260

Thailand

Founded in 1982

Key Executives for Mega Lifesciences Public Company Limited

Mega Lifesciences Public Company Limited does not have any Key Executives recorded.

Mega Lifesciences Public Company Limited Key Developments

Mega Lifesciences Public Company Limited, Board Meeting, Aug 13, 2014

Mega Lifesciences Public Company Limited, Board Meeting, Aug 13, 2014., at 07:30 Indian Standard Time. Agenda: To consider to approve the payments of interim dividends.

Mega Lifesciences Public Company Limited Announces Consolidated and Company Earnings Results for Second Quarter and Six Months Ended June 30, 2014

Mega Lifesciences Public Company Limited announced consolidated and company earnings results for second quarter and six months ended June 30, 2014. For second quarter, on consolidated basis the company reported operating revenue was THB 1,958.8 million compared to THB 1,764.0 million a year ago. Total Income was THB 1,969.1 million compared to 1,768.7 million a year ago. EBITDA was THB 186.9 million compared to THB 256.1 million a year ago. Earnings before interest & tax (EBIT) was THB 153.2 million compared to THB 233.0 million a year ago. Profit before tax was THB 148.6 million compared to THB 225.4 million to a year ago. Net Profit was THB 129.1 million compared to THB 180.4 million a year ago. EPS was THB 0.15 compared to THB 0.25 a year ago. On company basis, for the quarter reported net profit was THB 75,145,000 or EPS of 0.09 compared to THB 215,245,000 or EPS of THB 0.30 a year ago. For first half, the company reported operating revenue was THB 3,664.0 million compared to THB 3,293.5 million a year ago. Total income was THB 3,683.4 million compared to THB 3,308.3 million a year ago. EBITDA was THB 283.9 million compared to THB 411.9 million a year ago. Earnings before interest & tax (EBIT) was THB 218.7 million compared to THB 364.3 million a year ago. Profit before tax was THB 209.4 million compared to THB 349.4 million a year ago. Net profit was THB 185.7 million compared to THB 293.7 million a year ago. EPS was THB 0.21 compared to THB 0.40 a year ago. On company basis, for the six months reported net profit was THB 455,174,000 or EPS of 0.53 compared to THB 253,012,000 or EPS of THB 0.35 a year ago.

Mega Lifesciences Public Company Limited Presents at Citi Asean Investor Conference 2014, Jun-13-2014 12:45 PM

Mega Lifesciences Public Company Limited Presents at Citi Asean Investor Conference 2014, Jun-13-2014 12:45 PM. Venue: Ritz Carlton Hotel, Singapore. Speakers: Vivek Dhawan, Chief Executive Officer, Chief Coach, Director and Member of Nomination & Remuneration Committee.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mega Lifesciences Public Company Limited, please visit www.megawecare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.